THERAPEUTICSMD INC - COM (TXMD) Institutional Ownership

CUSIP: 88338N107

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2022

Type / Class
Equity / COM
Symbol
TXMD on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$138,000 0
2022 Q2 13,882 $138,000 -$40,657,805 $10.06 2
2022 Q1 106,249,720 $40,383,995 -$6,460,833 $0.38 107
2021 Q4 123,989,841 $44,113,283 -$5,136,500 $0.36 118
2021 Q3 132,623,961 $98,181,827 -$35,237,991 $0.74 143
2021 Q2 168,594,448 $200,534,644 -$7,293,146 $1.19 148
2021 Q1 174,027,984 $233,195,315 +$19,299,909 $1.34 154
2020 Q4 161,086,122 $195,000,979 +$2,870,955 $1.21 150
2020 Q3 157,569,577 $249,322,171 +$8,915,683 $1.58 139
2020 Q2 152,335,132 $190,408,846 -$36,023,732 $1.25 142
2020 Q1 182,844,612 $189,844,871 -$31,618,067 $1.06 135
2019 Q4 192,502,060 $466,882,212 +$46,177,594 $2.42 162
2019 Q3 172,591,588 $626,565,901 -$57,124,136 $3.63 145
2019 Q2 188,901,090 $489,428,303 -$20,791,317 $2.60 144
2019 Q1 191,057,703 $930,418,803 +$25,180,934 $4.87 139
2018 Q4 186,489,933 $710,578,290 +$23,585,017 $3.81 133
2018 Q3 178,040,270 $1,167,923,446 +$136,966,572 $6.56 151
2018 Q2 157,165,492 $980,713,228 -$29,803,080 $6.24 141
2018 Q1 162,504,460 $791,412,125 -$4,590,259 $4.87 139
2017 Q4 162,564,564 $981,884,925 -$9,661,276 $6.04 140
2017 Q3 164,535,449 $866,656,619 +$45,414,189 $5.29 132
2017 Q2 155,831,246 $821,246,855 -$59,727,020 $5.27 116
2017 Q1 164,032,510 $1,180,505,857 +$86,656,418 $7.20 133
2016 Q4 164,362,294 $948,393,873 +$51,055,130 $5.77 144
2016 Q3 155,172,033 $1,056,251,015 -$38,331,278 $6.81 134
2016 Q2 160,166,119 $1,361,401,786 +$63,580,566 $8.50 122
2016 Q1 152,957,072 $978,874,720 +$151,271,708 $6.40 127
2015 Q4 128,656,848 $1,334,216,025 +$78,466,830 $10.37 124
2015 Q3 122,266,742 $716,480,520 +$70,338,173 $5.86 113
2015 Q2 109,322,381 $859,225,513 -$17,806,752 $7.86 113
2015 Q1 112,516,421 $680,746,484 +$103,006,656 $6.05 93
2014 Q4 95,559,938 $425,226,112 +$1,098,617 $4.45 79
2014 Q3 95,310,793 $442,156,817 +$40,553,725 $4.64 80
2014 Q2 86,674,105 $383,021,167 -$34,265,495 $4.42 85
2014 Q1 91,996,558 $580,382,712 +$141,497,858 $6.31 81